Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Coronary Restenosis
- The Effects of Bindarit in Preventing Stent Restenosis
- XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
- Oral Sirolimus for In-Stent Restenosis
- Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents
- Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial
- Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation
- Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCI
- PIoglitazone for PrEvention of Restenosis in Diabetic Patients
- Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries
- Serp-1 for the Treatment of Acute Coronary Syndrome
- Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty
- Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis
- A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.